NO20031997L - CRF-reseptor-antagonist og metoder relatert dertil - Google Patents

CRF-reseptor-antagonist og metoder relatert dertil

Info

Publication number
NO20031997L
NO20031997L NO20031997A NO20031997A NO20031997L NO 20031997 L NO20031997 L NO 20031997L NO 20031997 A NO20031997 A NO 20031997A NO 20031997 A NO20031997 A NO 20031997A NO 20031997 L NO20031997 L NO 20031997L
Authority
NO
Norway
Prior art keywords
receptor antagonist
methods related
crf receptor
crf
methods
Prior art date
Application number
NO20031997A
Other languages
English (en)
Other versions
NO20031997D0 (no
Inventor
Mustapha Haddach
Marion C Lanier
Charles Q Huang
James R Mccarthy
Original Assignee
Neurocrine Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurocrine Biosciences Inc filed Critical Neurocrine Biosciences Inc
Publication of NO20031997L publication Critical patent/NO20031997L/no
Publication of NO20031997D0 publication Critical patent/NO20031997D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20031997A 2000-11-03 2003-05-02 CRF-reseptor-antagonist og metoder relatert dertil NO20031997D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24582100P 2000-11-03 2000-11-03
PCT/US2001/047919 WO2002040480A2 (en) 2000-11-03 2001-11-02 Crf receptor antagonists and methods relating thereto

Publications (2)

Publication Number Publication Date
NO20031997L true NO20031997L (no) 2003-05-02
NO20031997D0 NO20031997D0 (no) 2003-05-02

Family

ID=22928212

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031997A NO20031997D0 (no) 2000-11-03 2003-05-02 CRF-reseptor-antagonist og metoder relatert dertil

Country Status (11)

Country Link
US (2) US6747034B2 (no)
EP (1) EP1341793B1 (no)
JP (1) JP2004529075A (no)
KR (1) KR20030060927A (no)
AU (2) AU3958902A (no)
CA (1) CA2427656A1 (no)
DE (1) DE60126134T2 (no)
ES (1) ES2279835T3 (no)
MX (1) MXPA03003714A (no)
NO (1) NO20031997D0 (no)
WO (1) WO2002040480A2 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7273871B2 (en) * 2001-07-17 2007-09-25 Sb Pharmco Puerto Rico Inc. Phenyl-5,6,6A,7,8,9-hexahydro-4H-1,4,9-triaza-phenalene derivatives as CRF antagonists
CN102558155A (zh) 2003-01-14 2012-07-11 阿伦纳药品公司 作为代谢调节剂的芳基和杂芳基衍生物及其所涉及的疾病如糖尿病和高血糖症的预防和治疗
EP1680426B1 (en) * 2003-06-10 2007-09-19 F. Hoffmann-La Roche Ag 1.3.4-triaza-phenalene and 1,3,4,6-tetraazaphenalene derivatives
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
TWI335328B (en) 2003-07-14 2011-01-01 Arena Pharm Inc Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related hereto
US20060024661A1 (en) * 2003-07-30 2006-02-02 The Regents Of The University Of California Modulation of CRF potentiation of NMDA receptor currents via CRF receptor 2
DE602004012318T2 (de) * 2003-12-22 2009-03-12 Sb Pharmco Puerto Rico Inc. Crf-rezeptorantagonisten und diese betreffende verfahren
CA2576435A1 (en) * 2004-08-09 2006-03-23 Research Development Foundation Determination of the 3d-structure of an extracellular domain of a b1 g-protein coupled receptor by nmr analysis
WO2006081522A2 (en) * 2005-01-26 2006-08-03 The Regents Of The Unversity Of California Modulation of nmda receptor currents via orexin receptor and/or crf receptor
MX2013003184A (es) 2010-09-22 2013-06-07 Arena Pharm Inc Moduladores del receptor gpr119 y el tratamiento de transtornos relacionados con el mismo.
AU2016205361C1 (en) 2015-01-06 2021-04-08 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the S1P1 receptor
PL3310760T3 (pl) 2015-06-22 2023-03-06 Arena Pharmaceuticals, Inc. Krystaliczna sól L-argininy kwasu (R)-2-(7-(4-cyklopentylo-3-(trifluorometylo)benzyloksy)- 1,2,3,4-tetrahydrocyklo-penta[b]indol-3-ilo)octowego do zastosowania w zaburzeniach związanych z receptorem S1P1
KR20190116416A (ko) 2017-02-16 2019-10-14 아레나 파마슈티칼스, 인크. 원발 담즙성 담관염을 치료하기 위한 화합물 및 방법
AU2019280822A1 (en) 2018-06-06 2021-01-07 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the S1P1 receptor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1129096T3 (da) 1998-11-12 2003-09-15 Neurocrine Biosciences Inc CRF-receptorantagonister og fremgangsmåder, der er relateret dertil
ES2180338T3 (es) * 1998-11-12 2003-02-01 Neurocrine Biosciences Inc Antagonistas del receptor de crf y metodos relacionados.

Also Published As

Publication number Publication date
US20020151557A1 (en) 2002-10-17
WO2002040480A3 (en) 2003-05-15
JP2004529075A (ja) 2004-09-24
DE60126134D1 (de) 2007-03-08
AU2002239589B2 (en) 2005-04-21
EP1341793A2 (en) 2003-09-10
WO2002040480A2 (en) 2002-05-23
MXPA03003714A (es) 2004-05-04
AU3958902A (en) 2002-05-27
CA2427656A1 (en) 2002-05-23
US20040266799A1 (en) 2004-12-30
ES2279835T3 (es) 2007-09-01
DE60126134T2 (de) 2007-10-18
NO20031997D0 (no) 2003-05-02
EP1341793B1 (en) 2007-01-17
US6747034B2 (en) 2004-06-08
KR20030060927A (ko) 2003-07-16

Similar Documents

Publication Publication Date Title
NO20021361D0 (no) Fremgangsmåte for rask og omfattende formasjonsevaluering
IS7040A (is) 5-HT viðtakabindlar og notkun þeirra
DK1202941T3 (da) Gipssammensætninger og beslægtede fremgangsmåder
DK1122244T3 (da) Uracilforbindelser og anvendelse deraf
NO20013393D0 (no) Brönnsementeringsfremgangsmåter og sammensetninger
NO20024874L (no) Benzoamidpiperidin-inneholdende forbindelser og beslektede forbindelser
NO20024355L (no) Nukleosidforbindelser og anvendelser derav
NO20014553D0 (no) Brönnplanlegging og konstruksjon
DK2325317T3 (da) Receptornukleinsyrer og polypeptidr
NO20021449D0 (no) Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og anvendelse derav
DK1251848T3 (da) Gyraseinhibitorer og anvendelse deraf
NO20032668L (no) Gyraseinhibitorer og anvendelser derav
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
IS6802A (is) 3-arýlindólafleiður og notkun þeirra sem CB2 viðtakagerandefni
NO20030471D0 (no) Karboksamidforbindelser og deres anvendelse som antagonister for en 11CBY-reseptor
DK1322597T3 (da) Fremgangsmåde og intermediære
NO20032542L (no) Dempede anti-CD28-antistoffer og anvendelse derav
NO20031997D0 (no) CRF-reseptor-antagonist og metoder relatert dertil
NO20030228D0 (no) Antennestruktur og assosiert fremgangsmåte
IS8526A (is) CRF viðtakamótlyf og aðferðir tengdar þeim
DK1334106T3 (da) Imidazolderivater, fremstillingsmetoder deraf og anvendelse deraf
NO20030822L (no) Nye forbindelser og fremgangsmåter
IS7438A (is) Lyfjablanda úr PDE4 eða PDE3/4 tálma og histamínviðtakamótlyfi
NO20042500L (no) Chemokin-reseptorantagonister og metoder for anvendelse derav
NO20032821D0 (no) Sea-trosy og beslektede fremgangsmåter

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application